Early phase clinical supply solutions are core to Ardena. Our expertise includes phase appropriate development and manufacturing under cGMP conditions of both drug substance (DS) and drug products (DP).
We support customers with short lead times by centralizing and developing processes, analytical methods and formulations in-house. Recognized for our regulatory track record and with a multidisciplinary team of DS, DP and RA CMC experts, we expedite your project collaboratively to meet your first-patient-in targets.
Access the full info sheet here.
